Medifast (MED) News Today $13.01 -0.09 (-0.69%) Closing price 05/6/2025 03:59 PM EasternExtended Trading$13.01 0.00 (0.00%) As of 04:27 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Medifast (NYSE:MED) Upgraded by StockNews.com to Buy RatingMay 3, 2025 | americanbankingnews.comEarnings Release: Here's Why Analysts Cut Their Medifast, Inc. (NYSE:MED) Price Target To US$15.00May 2, 2025 | finance.yahoo.comMedifast First Quarter 2025 Earnings: EPS Beats ExpectationsMay 1, 2025 | finance.yahoo.comMedifast (NYSE:MED) Releases Q2 2025 Earnings GuidanceMedifast (NYSE:MED) updated its second quarter 2025 earnings guidance. The company provided EPS guidance of -0.550-0.000 for the period, compared to the consensus estimate of -0.070. The company also issued revenue guidance of $85.0 millionillion-$105.0 millionillion, compared to the consensus estimate of $112.3 millionillion.April 30, 2025 | marketbeat.comMedifast (NYSE:MED) Posts Quarterly Earnings Results, Beats Expectations By $0.09 EPSMedifast (NYSE:MED - Get Free Report) posted its earnings results on Monday. The specialty retailer reported ($0.11) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.20) by $0.09. Medifast had a return on equity of 10.64% and a net margin of 0.35%.April 30, 2025 | marketbeat.comMedifast’s Earnings Call: Mixed Sentiment Amid ChallengesApril 29, 2025 | tipranks.comMedifast, Inc. (NYSE:MED) Q1 2025 Earnings Call TranscriptApril 29, 2025 | msn.comQ1 2025 Medifast Inc Earnings CallApril 29, 2025 | finance.yahoo.comMarshall Wace LLP Takes $1.84 Million Position in Medifast, Inc. (NYSE:MED)Marshall Wace LLP purchased a new position in shares of Medifast, Inc. (NYSE:MED - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 104,226 shares of the specialty retailer's stock, valued at approximately $1April 29, 2025 | marketbeat.comMedifast Q1 2025 slides: Adapting strategy for GLP-1 era amid revenue challengesApril 29, 2025 | investing.comMedifast shares drop as revenue misses estimates, guidance disappointsApril 29, 2025 | investing.comMedifast Announces First Quarter 2025 Financial ResultsApril 29, 2025 | finance.yahoo.comMedifast Inc (MED) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic FocusApril 29, 2025 | uk.finance.yahoo.comMedifast (NYSE:MED) Misses Q1 Sales TargetsApril 29, 2025 | msn.comMedifast projects Q2 2025 revenue of $85M-$105M amid coach strategy enhancementsApril 29, 2025 | msn.comQ1 2025 Medifast Inc Earnings Call TranscriptApril 29, 2025 | gurufocus.comU.S. Meal Replacements Market Faces $1.5 Billion Setback Due to GLP-1 Drugs - U.S. Meal Replacements Market Report 2025April 28, 2025 | finance.yahoo.comEarnings To Watch: Medifast (MED) Reports Q1 Results TomorrowApril 27, 2025 | msn.comMedifast (MED) Projected to Post Earnings on MondayApril 27, 2025 | americanbankingnews.comJPMorgan Chase & Co. Increases Stock Position in Medifast, Inc. (NYSE:MED)JPMorgan Chase & Co. boosted its holdings in shares of Medifast, Inc. (NYSE:MED - Free Report) by 103.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 117,157 shares of the specialty retailer's stockApril 27, 2025 | marketbeat.comUncovering Potential: Medifast's Earnings PreviewApril 25, 2025 | benzinga.comMedifast (MED) Projected to Post Quarterly Earnings on MondayMedifast (NYSE:MED) will be releasing earnings after the market closes on Monday, April 28, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=683729)April 23, 2025 | marketbeat.comRenaissance Technologies LLC Decreases Position in Medifast, Inc. (NYSE:MED)Renaissance Technologies LLC lowered its stake in shares of Medifast, Inc. (NYSE:MED - Free Report) by 10.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 903,734 shares of the specialty retailer's stock after sellingApril 17, 2025 | marketbeat.comMedifast to Announce Financial Results for the First Quarter Ended March 31, 2025April 14, 2025 | gurufocus.comMedifast to Announce Financial Results for the First Quarter Ended March 31, 2025 | MED Stock NewsApril 14, 2025 | gurufocus.comMedifast, Inc. (NYSE:MED) Shares Sold by Quinn Opportunity Partners LLCQuinn Opportunity Partners LLC cut its position in Medifast, Inc. (NYSE:MED - Free Report) by 38.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 71,607 shares of the specialty retailer's stock after sellingApril 14, 2025 | marketbeat.comMedifast, Inc. (NYSE:MED) Shares Purchased by Federated Hermes Inc.Federated Hermes Inc. increased its stake in shares of Medifast, Inc. (NYSE:MED - Free Report) by 28.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 279,473 shares of the specialty retailer's stock after buying anApril 14, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Sells 180,332 Shares of Medifast, Inc. (NYSE:MED)Arrowstreet Capital Limited Partnership lessened its stake in Medifast, Inc. (NYSE:MED - Free Report) by 77.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 51,396 shares of the specialty retailer's stock after selling 180April 14, 2025 | marketbeat.comMedifast, Inc. (NYSE:MED) Shares Sold by Trexquant Investment LPTrexquant Investment LP trimmed its position in Medifast, Inc. (NYSE:MED - Free Report) by 44.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 58,304 shares of the specialty retailer's stock after selling 47,206 shares during the periApril 13, 2025 | marketbeat.comPersonal Care Stocks Q4 Results: Benchmarking Medifast (NYSE:MED)April 10, 2025 | msn.comPrudential Financial Inc. Lowers Holdings in Medifast, Inc. (NYSE:MED)Prudential Financial Inc. lowered its position in shares of Medifast, Inc. (NYSE:MED - Free Report) by 37.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 46,485 shares of the specialty retailer's stock aftApril 9, 2025 | marketbeat.com3 Reasons MED is Risky and 1 Stock to Buy InsteadApril 8, 2025 | finance.yahoo.comLandscape Capital Management L.L.C. Buys New Stake in Medifast, Inc. (NYSE:MED)Landscape Capital Management L.L.C. purchased a new position in shares of Medifast, Inc. (NYSE:MED - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 32,734 shares of the specialty retailer's stock, valued aApril 8, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Sells 34,098 Shares of Medifast, Inc. (NYSE:MED)Charles Schwab Investment Management Inc. trimmed its stake in Medifast, Inc. (NYSE:MED - Free Report) by 23.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 114,138 shares of the specialty retailer's stock after seMarch 30, 2025 | marketbeat.comMedifast: GLP-1 Caused A Vicious MLM Flywheel EffectMarch 28, 2025 | seekingalpha.comMedifast management to meet virtually with StephensMarch 22, 2025 | markets.businessinsider.comAmundi Invests $374,000 in Medifast, Inc. (NYSE:MED)Amundi acquired a new position in Medifast, Inc. (NYSE:MED - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 21,215 shares of the specialty retailer's stock, valued at approximatMarch 21, 2025 | marketbeat.comZacks Research Has Strong Estimate for Medifast Q1 EarningsMedifast, Inc. (NYSE:MED - Free Report) - Research analysts at Zacks Research lifted their Q1 2025 EPS estimates for Medifast in a research note issued on Monday, March 10th. Zacks Research analyst R. Department now anticipates that the specialty retailer will post earnings of ($0.07) per share fMarch 14, 2025 | marketbeat.comZacks Research Issues Negative Outlook for Medifast EarningsMedifast, Inc. (NYSE:MED - Free Report) - Research analysts at Zacks Research cut their Q2 2025 EPS estimates for Medifast in a note issued to investors on Monday, March 10th. Zacks Research analyst R. Department now forecasts that the specialty retailer will post earnings per share of $0.24 forMarch 12, 2025 | marketbeat.com110,000 Shares in Medifast, Inc. (NYSE:MED) Bought by Prescott Group Capital Management L.L.C.Prescott Group Capital Management L.L.C. purchased a new stake in shares of Medifast, Inc. (NYSE:MED - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 110,000 shares of the specialty retaiMarch 8, 2025 | marketbeat.comWhat is DA Davidson's Forecast for Medifast Q1 Earnings?Medifast, Inc. (NYSE:MED - Free Report) - Equities research analysts at DA Davidson issued their Q1 2025 earnings per share (EPS) estimates for shares of Medifast in a report issued on Thursday, February 20th. DA Davidson analyst L. Weiser anticipates that the specialty retailer will post earningFebruary 24, 2025 | marketbeat.comDA Davidson Cuts Medifast (NYSE:MED) Price Target to $16.50DA Davidson cut their price objective on Medifast from $17.00 to $16.50 and set a "neutral" rating for the company in a research report on Wednesday.February 20, 2025 | marketbeat.comMedifast Full Year 2024 Earnings: EPS Beats ExpectationsFebruary 20, 2025 | finance.yahoo.comQ4 2024 Medifast Inc Earnings CallFebruary 20, 2025 | finance.yahoo.comMedifast sees Q1 revenue $100M-$120MFebruary 20, 2025 | markets.businessinsider.comMedifast reports Q4 adjusted EPS 10c vs. $1.09 last yearFebruary 20, 2025 | markets.businessinsider.comMedifast, Inc. (NYSE:MED) Q4 2024 Earnings Call TranscriptFebruary 20, 2025 | msn.comMedifast (NYSE:MED) Posts Earnings Results, Beats Estimates By $0.26 EPSMedifast (NYSE:MED - Get Free Report) announced its earnings results on Tuesday. The specialty retailer reported $0.10 EPS for the quarter, topping the consensus estimate of ($0.16) by $0.26. Medifast had a return on equity of 15.98% and a net margin of 1.09%.February 19, 2025 | marketbeat.comMedifast (NYSE:MED) Issues Q1 2025 Earnings GuidanceMedifast (NYSE:MED) updated its first quarter 2025 earnings guidance. The company provided EPS guidance of -0.500-0.000 for the period, compared to the consensus estimate of -0.190. The company also issued revenue guidance of $100.0 millionillion-$120.0 millionillion, compared to the consensus estimate of $130.8 millionillion.February 19, 2025 | marketbeat.comMedifast Faces Revenue Challenges Amid New Product LaunchFebruary 19, 2025 | tipranks.com Get Medifast News Delivered to You Automatically Sign up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter. Email Address MED Media Mentions By Week MED Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MED News Sentiment▼0.050.78▲Average Consumer Staples News Sentiment MED News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MED Articles This Week▼53▲MED Articles Average Week Get Medifast News Delivered to You Automatically Sign up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies USNA News Today NUS News Today NATR News Today VERU News Today EL News Today PBH News Today IPAR News Today HLF News Today FARM News Today JVA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MED) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medifast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MED Stock Free MED Stock Alerts